Campbell & CO Investment Adviser LLC Organogenesis Holdings Inc. Transaction History

Campbell & CO Investment Adviser LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $44,566 - $91,260	14,193 New	14,193 $46,000
Q2 2022 Aug 09, 2022	SELL	$4.74 - $8.15 $100,644 - $173,048	-21,233 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$6.47 - $9.57 $29,975 - $44,337	4,633 Added 27.91%	21,233 $162,000
Q4 2021 Feb 10, 2022	BUY	$9.02 - $13.5 $23,452 - $35,100	2,600 Added 18.57%	16,600 $153,000
Q3 2021 Nov 10, 2021	BUY	$13.71 - $17.18 $191,940 - $240,520	14,000 New	14,000 $199,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.